Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants - PubMed (original) (raw)
Clinical Trial
Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants
Jan Knol et al. J Pediatr Gastroenterol Nutr. 2005 Jan.
Abstract
Objectives: The intestinal flora of breast-fed infants is generally dominated by Bifidobacteria. We aimed to investigate whether an infant formula supplemented with galacto-oligosaccharides and fructo-oligosaccharides (GOS/FOS) is able to establish a bifido-dominant microflora, not only in numbers but also with respect to the metabolic activity in the colon.
Methods: Two groups of infants fed infant formula with 0.8 g/100 ml GOS/FOS in a ratio of 9:1 (OSF group), or control formula (SF group) were evaluated in a randomised, double blind, placebo controlled intervention study. A breast-fed group was studied in parallel. At study onset and after 4 and 6 weeks, faecal samples were examined for the number of bifidobacteria, pH, short chain fatty acids and lactate.
Results: After 6 weeks, the mean proportion of bifidobacteria was significantly higher in the OSF group (59.6% versus 49.5% in the SF group; P < 0.05). Compared with controls, infants in the OSF group had a lower stool mean pH and an increased proportion of acetate and a decreased proportion of propionate. The mean pH in the OSF and SF groups were 5.7 and 6.3, respectively (P < 0.001).
Conclusions: The addition of the prebiotic GOS/FOS mixture to an infant formula has a stimulating effect on the growth of bifidobacteria and on the metabolic activity of the total intestinal flora. The changes in short chain fatty acids, lactate and pH in the prebiotic group represent a fermentation profile that is closer to that observed in breast-fed infants compared to infants fed control formula.
Similar articles
- Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life.
Bakker-Zierikzee AM, Alles MS, Knol J, Kok FJ, Tolboom JJ, Bindels JG. Bakker-Zierikzee AM, et al. Br J Nutr. 2005 Nov;94(5):783-90. doi: 10.1079/bjn20051451. Br J Nutr. 2005. PMID: 16277782 Clinical Trial. - Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial.
Holscher HD, Faust KL, Czerkies LA, Litov R, Ziegler EE, Lessin H, Hatch T, Sun S, Tappenden KA. Holscher HD, et al. JPEN J Parenter Enteral Nutr. 2012 Jan;36(1 Suppl):95S-105S. doi: 10.1177/0148607111430087. JPEN J Parenter Enteral Nutr. 2012. PMID: 22237884 Clinical Trial. - The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants.
Costalos C, Kapiki A, Apostolou M, Papathoma E. Costalos C, et al. Early Hum Dev. 2008 Jan;84(1):45-9. doi: 10.1016/j.earlhumdev.2007.03.001. Epub 2007 Apr 11. Early Hum Dev. 2008. PMID: 17433577 Clinical Trial. - Prebiotics in infant formulas.
Boehm G, Jelinek J, Stahl B, van Laere K, Knol J, Fanaro S, Moro G, Vigi V. Boehm G, et al. J Clin Gastroenterol. 2004 Jul;38(6 Suppl):S76-9. doi: 10.1097/01.mcg.0000128927.91414.93. J Clin Gastroenterol. 2004. PMID: 15220664 Review. - Oligosaccharides in infant formula: more evidence to validate the role of prebiotics.
Vandenplas Y, Zakharova I, Dmitrieva Y. Vandenplas Y, et al. Br J Nutr. 2015 May 14;113(9):1339-44. doi: 10.1017/S0007114515000823. Br J Nutr. 2015. PMID: 25989994 Review.
Cited by
- Enzymes for production of whey protein hydrolysates and other value-added products.
Irazoqui JM, Santiago GM, Mainez ME, Amadio AF, Eberhardt MF. Irazoqui JM, et al. Appl Microbiol Biotechnol. 2024 May 31;108(1):354. doi: 10.1007/s00253-024-13117-2. Appl Microbiol Biotechnol. 2024. PMID: 38819482 Free PMC article. Review. - Comparative prebiotic potential of galacto- and fructo-oligosaccharides, native inulin, and acacia gum in Kenyan infant gut microbiota during iron supplementation.
Momo Cabrera P, Rachmühl C, Derrien M, Bourdet-Sicard R, Lacroix C, Geirnaert A. Momo Cabrera P, et al. ISME Commun. 2024 Mar 11;4(1):ycae033. doi: 10.1093/ismeco/ycae033. eCollection 2024 Jan. ISME Commun. 2024. PMID: 38774131 Free PMC article. - Prebiotics increase iron absorption and reduce the adverse effects of iron on the gut microbiome and inflammation: a randomized controlled trial using iron stable isotopes in Kenyan infants.
Mikulic N, Uyoga MA, Stoffel NU, Derrien M, Nyilima S, Kostopoulos I, Roeselers G, Chenoll E, Mwasi E, Pironaci G, Karanja S, Bourdet-Sicard R, Zimmermann MB. Mikulic N, et al. Am J Clin Nutr. 2024 Feb;119(2):456-469. doi: 10.1016/j.ajcnut.2023.11.018. Epub 2023 Nov 30. Am J Clin Nutr. 2024. PMID: 38042412 Clinical Trial. - Dietary Fibers in Healthy Children and in Pediatric Gastrointestinal Disorders: A Practical Guide.
Salvatore S, Battigaglia MS, Murone E, Dozio E, Pensabene L, Agosti M. Salvatore S, et al. Nutrients. 2023 May 6;15(9):2208. doi: 10.3390/nu15092208. Nutrients. 2023. PMID: 37432354 Free PMC article. Review. - Taste Responses and Ingestive Behaviors to Ingredients of Fermented Milk in Mice.
Yamase Y, Huang H, Mitoh Y, Egusa M, Miyawaki T, Yoshida R. Yamase Y, et al. Foods. 2023 Mar 8;12(6):1150. doi: 10.3390/foods12061150. Foods. 2023. PMID: 36981077 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical